Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southwest Pharmaceutical Factory No. 2 is a historical pharmaceutical manufacturing entity based in Chongqing, China, that played a foundational role in the region's chemical drug industry. Originally established as a state-owned enterprise, the factory specialized in the mass production of essential medicines, including analgesics, antipyretics, and antibiotics. It was particularly noted for its large-scale manufacturing of paracetamol and other active pharmaceutical ingredients (APIs). The company underwent significant restructuring and was eventually integrated into Southwest Pharmaceutical Co., Ltd., which is now a key subsidiary of the Taiji Group. Its facilities continue to operate as major manufacturing hubs for chemical formulations and bulk drugs under the parent organization's umbrella.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 重庆西南制药二厂.